CCot: Cardboard Cot in Neonatal Thermoregulation: A Randomized Cross Over Trial

Sponsor
University of Alabama at Birmingham (Other)
Overall Status
Withdrawn
CT.gov ID
NCT03344978
Collaborator
(none)
0
2
27.6

Study Details

Study Description

Brief Summary

This study will determine whether the efficacy of Mylar-lined cardboard cots is equivalent to traditional incubators in their ability to prevent hypothermia (axillary temperature < 36° C) in preterm neonates <36 6/7 weeks gestational age in a randomized cross-over designed trial. Infants will be randomized to receive care in the cardboard cot or incubator and then cross over to the other device for 24 hour periods, rotating for a total of 96 hours total trial time.

Condition or Disease Intervention/Treatment Phase
  • Other: Cardboard Cot Care
  • Other: Incubator Care
N/A

Detailed Description

The aim of the trial is to determine whether a corrugated cardboard cot will assist in maintaining infant axillary temperatures comparing it to the temperatures of the same infant being nursed in low heat incubators. The study will be done in the context of standard medical care, including the WHO thermoregulation protocol (warm delivery rooms, immediate drying after birth, early and exclusive breastfeeding, postponement of bathing and weighing, and appropriate bundling).

The cardboard cot is approximately 24 inches long to accommodate the length of the infant and about 12 inches wide to accommodate term infants, even beyond the first months after birth. The cots are fully lined with a reflective metallized film sheet of Mylar. The cot will be covered with a cardboard piece also lined in reflective film up to about the infant's shoulders so that the infant's face is visible. Attached to the lid is a 5 inch cardboard flap lined with reflective film which folds down into the body of the cot to reduce heat loss.

Infants ≤ 36 6/7 weeks gestation will be randomized to receive care in a cardboard cot or an incubator. Infants will begin care in one device and after 24 hours will cross over to the other device for another 24 hours. The process will be repeated once more for a total of 96 hours of study duration. The infants will be normothermic and stable when they are enrolled in the trial. Axillary temperatures will be measured at 1 hr, 6 hours and 24 hours after being placed in the cost or incubator. Infants with observed hypothermia (<36° C) will have measures taken to increase temperature (i.e. adding blankets, hat).

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Randomized crossover. Participant will be randomly assigned initially to care in one of two devices for 24 hours, then crossed over to other device for 24 hours. This will be repeated once more for a total of 96 hours study time. Patterns may be A-B-A-B or B-A-B-A.Randomized crossover. Participant will be randomly assigned initially to care in one of two devices for 24 hours, then crossed over to other device for 24 hours. This will be repeated once more for a total of 96 hours study time. Patterns may be A-B-A-B or B-A-B-A.
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Cardboard Cot in Neonatal Thermoregulation: A Randomized Cross Over Trial in Prevention of Moderate or Severe Hypothermia in Preterm Infants Requiring at Least 1 Week of Incubator
Actual Study Start Date :
Jun 11, 2019
Actual Primary Completion Date :
Sep 27, 2021
Actual Study Completion Date :
Sep 27, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Cardboard Cot Care

Stable infant will be nursed in a cardboard cot, lined with reflective film for 24 hour period of time. Infant's axillary temperature will be taken at 1 hour after randomization, at 6 hours after randomization, and 24 hours after randomization. After 24 hours, infant will be swapped to the other arm (Incubator Care), and back for a total of 2 24-hour periods in each arm.

Other: Cardboard Cot Care
Infant maintained in reflective film-lined cot for a period of 24 hours. Axillary temperatures will be taken at 1 hour, 6 hours, and 24 hours after randomization. If temperatures found < 36° C. at any time, an additional blanket and hat will be added to infant to improve temperature. Infant may be moved to incubator or radiant warmer. All other care will be standard of care at University Teaching Hospital, including warm delivery rooms, immediate drying, postponed bathing and weighing, early and exclusive breastfeeding, and Kangaroo Mother Care as continuously as possible.
Other Names:
  • CCot
  • Placebo Comparator: Incubator Care

    Stable infant will be nursed in an incubator for 24 hour period of time. Infant's axillary temperature will be taken at 1 hour after randomization, at 6 hours after randomization, and 24 hours after randomization. After 24 hours, infant will be swapped to the other arm (Cardboard Cot Care), and back for a total of 2 24-hour periods in each arm.

    Other: Incubator Care
    Infant maintained in standard incubator for a period of 24 hours. Axillary temperatures will be taken at 1 hour, 6 hours, and 24 hours after randomization. If temperatures found < 36° C. at any time, an additional blanket and hat will be added to infant to improve temperature. All other care will be standard of care at University Teaching Hospital, including warm delivery rooms, immediate drying, postponed bathing and weighing, early and exclusive breastfeeding, and Kangaroo Mother Care as continuously as possible.

    Outcome Measures

    Primary Outcome Measures

    1. Moderate (32.-35.9° C) or Severe (<32.0° C) hypothermia per Axillary Temperature [1 hour after placement in warming device]

      Temperature taken via axilla for 1 minute duration

    2. Moderate (32.0-35.9° C) or Severe (<32.0° C) hypothermia per Axillary Temperature [6 hours after placement in warming device]

      Temperature taken via axilla for 1 minute duration

    3. Moderate (32.-35.9° C) or Severe (<32.0°C) hypothermia per Axillary Temperature [24 hours after placement in warming device]

      Temperature taken via axilla for 1 minute duration

    Secondary Outcome Measures

    1. Normothermia (Axillary temperature 36.0 - 38.0° C) [1-96 hours after beginning of study]

      Temperature taken via axilla for 1 minute duration

    2. Hypothermia (Axillary temperature < 36.0° C) [1-96 hours after beginning of study]

      Temperature taken via axilla for 1 minute duration

    3. Mean Axillary Temperature in each device [4 months]

      Average of all axillary temperatures taken per device

    4. Rate of Moderate hypothermia (32.0-35.9° C) after placement in warming device [1 hour after placement in warming device]

      Temperature taken via axilla for 1 minute duration

    5. Rate of Moderate hypothermia (32.0-35.9°C) after placement in warming device [6 hours after placement in warming device]

      Temperature taken via axilla for 1 minute duration

    6. Rate of Moderate hypothermia (32.0-35.9° C) after placement in warming device [24 hours after placement in warming device]

      Temperature taken via axilla for 1 minute duration

    7. Rate of Severe hypothermia (<32.0° C) after placement in warming device [1 hour after placemnt in warming device]

      Temperature taken via axilla for 1 minute duration

    8. Rate of Severe hypothermia (<32.0° C) after placement in warming device [6 hours after placement in warming device]

      Temperature taken via axilla for 1 minute duration

    9. Rate of Severe hypothermia (<32.0° C) after placement in warming device [24 hours after placement in warming device]

      Temperature taken via axilla for 1 minute duration

    10. Rate of Hyperthermia (>38.0°C) after placement in warming device [4 months]

      Temperature taken via axilla for 1 minute duration

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    1 Minute to 5 Days
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Estimated gestational age < 36 6/7 weeks

    • Hospitalized in the NICU at University Teaching Hospital in Zambia

    • Requiring incubator/radiant warmer for at least 1 week

    Exclusion Criteria:
    • Abdominal wall defect or myelomeningocele

    • Major congenital anomalies

    • Blistering skin disorder

    • Suspected Sepsis

    • Requiring ongoing respiratory support

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • University of Alabama at Birmingham

    Investigators

    • Principal Investigator: Colm P Travers, MB BCh BAO, University of Alabama at Birmingham

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Colm Travers, Principal Investigator, University of Alabama at Birmingham
    ClinicalTrials.gov Identifier:
    NCT03344978
    Other Study ID Numbers:
    • UAB Neo 018
    First Posted:
    Nov 17, 2017
    Last Update Posted:
    Oct 26, 2021
    Last Verified:
    Oct 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Colm Travers, Principal Investigator, University of Alabama at Birmingham
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 26, 2021